Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Neurology
    November 2021
  1. DUMONCEAU AG, Ameli R, Rogemond V, Ruiz A, et al
    Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study.
    Neurology. 2021 Nov 19. pii: WNL.0000000000013087.
    >> Share

    October 2021

  2. Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Oct 29. pii: WNL.0000000000013021.
    >> Share

  3. AMATO A
    Author Response: Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Neurology. 2021;97:841-842.
    >> Share

  4. WILLER J
    Reader Response: Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Neurology. 2021;97:841.
    >> Share

  5. TINTORE M, Cobo-Calvo A, Carbonell P, Arrambide G, et al
    Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome.
    Neurology. 2021;97:e1641-e1652.
    >> Share

  6. AA HOGLUND RA, Meyer HE, Stigum H, Torkildsen O, et al
    Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study.
    Neurology. 2021 Oct 25. pii: WNL.0000000000012957.
    >> Share

  7. KALINCIK T, Tremlett H, Ascherio A
    High BMI In Youths as a Modifiable Risk Factor for Multiple Sclerosis: Weighing Up the Evidence.
    Neurology. 2021 Oct 25. pii: WNL.0000000000012966.
    >> Share

  8. AGHAJAN Y, Mitchell RN, Bhattacharyya S, Hsu TY, et al
    Teaching NeuroImage: Bilateral Middle Cerebellar Peduncle Stroke in Giant Cell Arteritis.
    Neurology. 2021 Oct 19. pii: WNL.0000000000012953.
    >> Share

  9. JANDRIC D, Lipp I, Paling D, Rog D, et al
    Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012834.
    >> Share

  10. SANCHEZ CV, Theel E, Binnicker M, Toledano M, et al
    Autoimmune Encephalitis Post-SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Neurology. 2021 Oct 11. pii: WNL.0000000000012931.
    >> Share

  11. SIMPSON-YAP S, De Brouwer E, Kalincik T, Rijke N, et al
    Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012753.
    >> Share

  12. KILLESTEIN J, Schoonheim MM, Voskuhl RR
    B-Cell Depletion and COVID-19 Severity in Multiple Sclerosis: Remaining Challenges.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012754.
    >> Share

  13. BONACCHI R, Meani A, Pagani E, Marchesi O, et al
    Association of Age at Onset With Gray Matter Volume and White Matter Microstructural Abnormalities in People With Multiple Sclerosis.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012869.
    >> Share

  14. HACOHEN Y, Eshaghi A
    Multiple Sclerosis in Children and Adults: Does Age Matter?
    Neurology. 2021 Oct 4. pii: WNL.0000000000012866.
    >> Share

    September 2021
  15. ZHAO-FLEMING HH, Valencia Sanchez C, Sechi E, Inbarasu J, et al
    CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
    Neurology. 2021;97:e1351-e1358.
    >> Share

  16. MERLO D, Stankovich J, Bai C, Kalincik T, et al
    Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012850.
    >> Share

  17. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Colorectal Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
    Neurology. 2021 Sep 15. pii: WNL.0000000000012634.
    >> Share

  18. TOBIN O
    Early Diagnosis and Treatment is Associated With Improved Outcomes in Patients With Multiple Sclerosis.
    Neurology. 2021 Sep 14. pii: WNL.0000000000012738.
    >> Share

  19. CAMELO-FILHO AE, Estephan EP, Heise CO, Zanoteli E, et al
    Teaching Video NeuroImage: Reflex Facilitation in Lambert-Eaton Myasthenic Syndrome.
    Neurology. 2021;97:e1168-e1169.
    >> Share

  20. GOLDSCHMIDT C, Fox RJ
    Relationship Between Serum Neurofilament Light and Multiple Sclerosis Disability Progression: Clear as Mud.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012755.
    >> Share

  21. TOBIN WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, et al
    Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012782.
    >> Share

  22. BRIDEL C, Leurs CE, van Lierop ZY, van Kempen ZL, et al
    Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012752.
    >> Share

  23. RADCLIFFE C, Potnis K, Peng TJ, DeCroce-Movson E, et al
    Teaching NeuroImage: Papilledema and Pachymeningitis: An Atypical Presentation of Granulomatosis With Polyangiitis.
    Neurology. 2021;97:e1060-e1061.
    >> Share

  24. YEH EA, Bourdette D, Wiendl H
    Longer-Term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012716.
    >> Share

  25. HAUSER SL, Kappos L, Montalban X, Craveiro L, et al
    Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012700.
    >> Share

  26. PALLADINO R, Chataway J, Majeed A, Marrie RA, et al
    Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort Study.
    Neurology. 2021 Sep 1. pii: WNL.0000000000012610.
    >> Share

  27. SALTER A
    Assessment of Biological Interactions Between MS Status and Depression for Mortality.
    Neurology. 2021 Sep 1. pii: WNL.0000000000012615.
    >> Share

    August 2021
  28. RICE J, Xiang XM
    Comparing the Effectiveness of Therapies in People With Secondary Progressive Multiple Sclerosis.
    Neurology. 2021;97:e972-e974.
    >> Share

  29. DOBSON R, Salter A
    Differing Impact of Disease-Modifying Therapy on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?
    Neurology. 2021;97:407-408.
    >> Share

  30. KOCH MW, Mostert JP, Wolinsky JS, Lublin FD, et al
    Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Aug 25. pii: WNL.0000000000012690.
    >> Share

  31. PETERSSON M, Feresiadou A, Jons D, Ilinca A, et al
    Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012604.
    >> Share

  32. KOCH MW, Mostert J, Zhang Y, Wolinsky JS, et al
    Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012603.
    >> Share

  33. FREY J, Kramer J, Castellani R, Sriwastava S, et al
    Clinical Reasoning: A 47-Year-Old With Headache, Vertigo, and Double Vision.
    Neurology. 2021;97:e535-e539.
    >> Share

  34. STRUPP M, Frenzel C, Goldschagg N, Halmagyi GM, et al
    Teaching Video NeuroImage: One Bedside Test, 2 Clinical Signs: One Vestibular, the Other Ocular Motor.
    Neurology. 2021;97:e541-e542.
    >> Share

    July 2021
  35. KARCESKI S
    Myasthenia Gravis: Which Type of Surgery Is Best?
    Neurology. 2021;97:e433-e435.
    >> Share

  36. CHEN T
    Clinical Reasoning: A 68-Year-Old Man With Proximal Weakness and Seizures.
    Neurology. 2021;97:e423-e428.
    >> Share

  37. SECHI E, Krecke KN, Messina SA, Buciuc M, et al
    Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012467.
    >> Share

  38. RASMINSKY M
    GCA Squared.
    Neurology. 2021;97:90-91.
    >> Share

  39. NICHOLAS RS, Rhone EE, Mariottini A, Silber E, et al
    Autologous Haematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: a Real-world Case Series.
    Neurology. 2021 Jul 12. pii: WNL.0000000000012449.
    >> Share

  40. LISAK RP
    [Editorial] At the Junction Where It Happens: Antibodies to LRP4 and Agrin Are Pathogenic in Myasthenia Gravis [re: M/S #2020/169756].
    Neurology. 2021 Jul 7. pii: WNL.0000000000012471.
    >> Share

  41. YU Z, Zhang M, Jing H, Chen P, et al
    Characterization of LRP4/Agrin Antibodies From a Patient with Myasthenia Gravis.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012463.
    >> Share

  42. HACOHEN Y, Kerr W, Waters P
    Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice.
    Neurology. 2021;97:12-13.
    >> Share

  43. AKAISHI T, Takahashi T, Misu T, Kaneko K, et al
    Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2021;97:e1-e12.
    >> Share

  44. GUASP M, Gine-Serven E, Maudes E, Rosa-Justicia M, et al
    Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
    Neurology. 2021;97:e61-e75.
    >> Share

    June 2021
  45. GRAY-RONCAL K, Fitzgerald K, Ryerson LZ, Charvet L, et al
    Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis.
    Neurology. 2021 Jun 30. pii: WNL.0000000000012362.
    >> Share

  46. ROOS I, Leray E, Casey R, Horakova D, et al
    Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis.
    Neurology. 2021 Jun 30. pii: WNL.0000000000012354.
    >> Share

  47. MYERS KA
    Author Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
    Neurology. 2021;96:1105.
    >> Share

  48. FUJIMORI J, Nakashima I
    Reader Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
    Neurology. 2021;96:1104-1105.
    >> Share

  49. VILLACIEROS-ALVAREZ J, Ordas CM, Torres-Gaona G, Diez-Barrio A, et al
    Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy.
    Neurology. 2021;96:e2901-e2902.
    >> Share

  50. HUISKAMP M, Eijlers AJC, Broeders TAA, Pasteuning J, et al
    Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Jun 7. pii: WNL.0000000000012341.
    >> Share

  51. PREZIOSA P, Schoonheim MM
    Ongoing Axonal Injury in Chronic Active Lesions in Multiple Sclerosis: In-Vivo Quantification Using Serum Neurofilament.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012331.
    >> Share

  52. CAMPBELL CREE BA, Arnold DL, Chataway J, Chitnis T, et al
    Secondary Progressive Multiple Sclerosis: New Insights.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012323.
    >> Share

  53. MAGGI P, Kuhle J, Schadelin S, van der Meer F, et al
    Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012326.
    >> Share

    May 2021
  54. SAN MARTIN AH, Cuadrado CA, Arbizu MG, Rabano-Suarez P, et al
    Autoimmune Septin-5 Disease Presenting as Spinocerebellar Ataxia and Nystagmus.
    Neurology. 2021 May 24. pii: WNL.0000000000012240.
    >> Share

  55. ROLLOT F, Fauvernier M, Uhry Z, Vukusic S, et al
    Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
    Neurology. 2021 May 19. pii: WNL.0000000000012224.
    >> Share

  56. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
    Neurology. 2021 May 19. pii: WNL.0000000000012127.
    >> Share

  57. JOLLIFFE EA, Guo Y, Hardy TA, Morris PP, et al
    Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis.
    Neurology. 2021 May 19. pii: WNL.0000000000012230.
    >> Share

  58. TOOSY AT, Kapur K, Nair KV
    Is OCT a Viable Tool to Monitor Disease-Modifying Treatments in RRMS Yet?
    Neurology. 2021;96:927-928.
    >> Share

  59. DAY GS, Yarbrough MY, Kortvelyessy P, Pruss H, et al
    Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
    Neurology. 2021;96:e2546-e2557.
    >> Share

  60. TITULAER MJ, Day GS
    Autoimmune Encephalitis in First Episode Psychoses: All Smoke and No Fire?
    Neurology. 2021 May 12. pii: WNL.0000000000012195.
    >> Share

  61. GIANNOCCARO MP, Liguori R
    Author Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
    Neurology. 2021;96:918-919.
    >> Share

  62. SILVESTRI N
    Reader Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
    Neurology. 2021;96:918.
    >> Share

  63. NERSESJAN V, McWilliam O, Krarup LH, Kondziella D, et al
    Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review.
    Neurology. 2021 May 5. pii: WNL.0000000000012122.
    >> Share


  64. Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Neurology. 2021 May 4. pii: WNL.0000000000011825.
    >> Share

  65. SOLIS-PAZMINO P, Baiu I, Lincango-Naranjo E, Trope W, et al
    Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis.
    Neurology. 2021 May 4. pii: WNL.0000000000012153.
    >> Share

  66. FOX RJ, Kryscio RJ
    A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis.
    Neurology. 2021;96:833-834.
    >> Share

  67. KOCH MW, Sage K, Kaur S, Kim J, et al
    Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.
    Neurology. 2021;96:e2313-e2322.
    >> Share

  68. BAR-OR A, Herman A, Stokmaier D
    Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:870.
    >> Share

  69. HAHN N
    Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:870.
    >> Share

  70. SIEGLER JE, Galetta S
    Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:869.
    >> Share

    April 2021
  71. DUBESSY AL, Tezenas du Montcel S, Viala F, Assouad R, et al
    Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012120.
    >> Share

  72. ZOUVELOU V, Daponte A
    Teaching Video NeuroImages: Resolution of Ptosis After Forceful Eye Closure: Bedside Diagnosis of Myasthenia Gravis.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012100.
    >> Share

  73. LEAVITT VM, Dobson R, Svennigsson A
    Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012101.
    >> Share

  74. SHELLY S, Mills JR, Dubey D, McKeon A, et al
    Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012050.
    >> Share

  75. SALAVISA M, Serrazina F, Pires P, Correia AS, et al
    Teaching Video NeuroImages: Infratentorial Multiple Sclerosis Relapse Presenting as Continuous Hemifacial Myokymia.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012052.
    >> Share

  76. GASPERI C, Hapfelmeier A, Daltrozzo T, Schneider A, et al
    Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012074.
    >> Share

  77. SOLOMON AJ, Ascherio A
    Early Diagnosis of Multiple Sclerosis: Further Evidence for Missed Opportunity.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012087.
    >> Share


  78. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
    Neurology. 2021 Apr 23. pii: WNL.0000000000012021.
    >> Share

  79. EID K, Torkildsen OF, Aarseth J, Flemmen HO, et al
    Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012062.
    >> Share

  80. YEH WZ, Widyastuti PA, Van der Walt A, Stankovich J, et al
    Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
    Neurology. 2021 Apr 20. pii: WNL.0000000000012084.
    >> Share

  81. SHELLY S, Shouman K, Paul P, Engelstad J, et al
    Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus.
    Neurology. 2021;96:e2078-e2089.
    >> Share

  82. NISHIDA H, Kohyama K, Kumada S, Takanashi JI, et al
    Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children.
    Neurology. 2021;96:e2070-e2077.
    >> Share

  83. COLLONGUES N, Alves Do Rego C, Bourre B, Biotti D, et al
    Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder.
    Neurology. 2021;96:e2006-e2015.
    >> Share

  84. LAMBE J, Risher H, Filippatou AG, Murphy OC, et al
    Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011933.
    >> Share

  85. BOURDETTE D, Killestein J
    Quelling Public Fears about Guillain-Barre Syndrome and COVID-19 Vaccination.
    Neurology. 2021 Apr 6. pii: WNL.0000000000011882.
    >> Share

  86. MARQUEZ LOZA AM, Holroyd KB, Johnson SA, Pilgrim DM, et al
    Guillain- Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.
    Neurology. 2021 Apr 6. pii: WNL.0000000000011881.
    >> Share

  87. ALLEN JA, Pasnoor M, Dimachkie MM, Ajroud-Driss S, et al
    Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study.
    Neurology. 2021;96:e1876-e1886.
    >> Share

    March 2021
  88. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    >> Share

  89. GARDIN T, Longbrake EE
    Inducing or "Unmasking" Autoimmunity? The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events.
    Neurology. 2021 Mar 16. pii: WNL.0000000000011812.
    >> Share

  90. LAMBE J, Fitzgerald KC, Murphy OC, Filippatou AG, et al
    Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011788.
    >> Share

  91. VILLOSLADA P, Galetta SL, Toosy A
    Seeing the Finish Line: Can Baseline OCT Values Predict Long-Term Disability and Therapeutic Management in Multiple Sclerosis?
    Neurology. 2021 Mar 2. pii: WNL.0000000000011793.
    >> Share

  92. BANSAL P, Paul BS, Singh G
    Multiple Sclerosis Relapse Presenting As Sensorineural Hearing Loss.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011796.
    >> Share

    February 2021
  93. MUTHUSAMY K, Boyer S, Patterson M, Bierau J, et al
    Neuroimaging Findings in Inosine Triphosphate Pyrophosphohydrolase (ITPase) Deficiency.
    Neurology. 2021 Feb 16. pii: WNL.0000000000011719.
    >> Share

  94. KALAITZIDIS G, Calabresi PA
    Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis?
    Neurology. 2021 Feb 15. pii: WNL.0000000000011694.
    >> Share


  95. Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data.
    Neurology. 2021 Feb 12. pii: WNL.0000000000011677.
    >> Share

  96. SOLE G, Mathis S, Friedman D, Salort-Campana E, et al
    Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011669.
    >> Share

  97. ZEPHIR H, Poupart J, Deschamps R, Audoin B, et al
    Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
    Neurology. 2021;96:295-296.
    >> Share

  98. LEITE MI
    Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
    Neurology. 2021;96:294-295.
    >> Share

  99. DALAKAS MC
    Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?
    Neurology. 2021;96:239-240.
    >> Share

  100. BURT RK, Balabanov R, Han X, Quigley K, et al
    Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
    Neurology. 2021;96:e817-e830.
    >> Share

  101. RIM J, Byler M, Soldatos A, Notarangelo L, et al
    Opinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome.
    Neurology. 2021;96:e956-e959.
    >> Share

  102. VALLAT JM, Duchesne M, Corcia P, Richard L, et al
    The Wide Spectrum of Pathophysiologic Mechanisms of Paraproteinemic Neuropathy.
    Neurology. 2021;96:214-225.
    >> Share

  103. NISHI R, Koike H, Ohyama K, Fukami Y, et al
    Association Between IL-5 Levels and the Clinicopathologic Features of Eosinophilic Granulomatosis With Polyangiitis.
    Neurology. 2021;96:226-229.
    >> Share

    January 2021
  104. ALPING P, Burman J, Lycke J, Frisell T, et al
    Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Non-induction Therapies for Multiple Sclerosis.
    Neurology. 2021 Jan 29. pii: WNL.0000000000011545.
    >> Share

  105. BROWNLEE WJ, Galetta S
    Optic Nerve in Multiple Sclerosis Diagnostic Criteria: An Aye to the Eyes?
    Neurology. 2021;96:139-140.
    >> Share

  106. SORMANI MP, Tur C, Barkhof F
    Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?
    Neurology. 2021;96:141-142.
    >> Share

  107. SPAGNI G, Tricoli L, Modoni A, Monforte M, et al
    Clinical Reasoning: A 71-Year-Old Man Presenting With Acute Onset Dysarthria and Dysphagia.
    Neurology. 2021;96:180-184.
    >> Share

  108. BOFFA G, Massacesi L, Inglese M, Mariottini A, et al
    Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Neurology. 2021 Jan 20. pii: WNL.0000000000011461.
    >> Share

  109. LEAVITT VM, Rocca M
    Siponimod for Cognition in Secondary Progressive Multiple Sclerosis: Thinking Through the Evidence.
    Neurology. 2021;96:91-92.
    >> Share

  110. ROCCA MA, Valsasina P, Meani A, Gobbi C, et al
    Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011494.
    >> Share

  111. PAPP V, Magyari M, Aktas O, Berger T, et al
    Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.
    Neurology. 2021;96:59-77.
    >> Share

  112. GREEN C, Morrison H, Smith P, Golestani F, et al
    Teaching Neuroimages: COVID-19-Associated Acute Disseminated Encephalomyelitis With Corpus Callosal Hemorrhage.
    Neurology. 2021;96:e307-e308.
    >> Share

  113. BOVIS F, Kalincik T, Lublin F, Cutter G, et al
    Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.
    Neurology. 2021;96:e214-e227.
    >> Share

  114. SHAH S, Klassen BT, Flanagan EP
    Paroxysmal Dysarthria-Ataxia in Multiple Sclerosis.
    Neurology. 2021 Jan 5. pii: WNL.0000000000011498.
    >> Share

  115. KALINCIK T, Sormani MP, Tur C
    Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?
    Neurology. 2021;96:12-13.
    >> Share

    December 2020
  116. KALINCIK T, Diouf I, Sharmin S, Malpas C, et al
    Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
    Neurology. 2020 Dec 28. pii: WNL.0000000000011242.
    >> Share


  117. The 2013 clinical course descriptors for multiple sclerosis: A clarification.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011198.
    >> Share

  118. BENEDICT RHB, Tomic D, Cree BA, Fox R, et al
    Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses.
    Neurology. 2020 Dec 16. pii: WNL.0000000000011275.
    >> Share

  119. VIDAL-JORDANA A, Rovira A, Arrambide G, Otero-Romero S, et al
    Optic nerve region in multiple sclerosis diagnosis: the utility of visual evoked potentials.
    Neurology. 2020 Dec 16. pii: WNL.0000000000011339.
    >> Share

  120. LEVISON LS, Thomsen RW, Sindrup SH, Andersen H, et al
    Association of Hospital-Diagnosed Infections and Antibiotic Use with Risk of Developing Guillain-Barre Syndrome.
    Neurology. 2020 Dec 14. pii: WNL.0000000000011342.
    >> Share

  121. GRAUS F, Dalmau J
    Author response: Hashimoto encephalopathy in the 21st century.
    Neurology. 2020;95:1068.
    >> Share

  122. SHUBHAKARAN K
    Reader response: Hashimoto encephalopathy in the 21st century.
    Neurology. 2020;95:1067-1068.
    >> Share

  123. LEE MY, Yong KP, Hyun JW, Kim SH, et al
    Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder.
    Neurology. 2020;95:e3124-e3128.
    >> Share

  124. RUSS JB, Timbie CM, Li Y, Gonzalez-Giraldo E, et al
    Clinical Reasoning: An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions.
    Neurology. 2020;95:e3153-e3159.
    >> Share

  125. TANBOON J, Inoue M, Hirakawa S, Tachimori H, et al
    Pathological features of anti-Mi-2 dermatomyositis.
    Neurology. 2020 Dec 4. pii: WNL.0000000000011269.
    >> Share

  126. NISHIJIMA H, Suzuki C, Kon T, Nakamura T, et al
    Bilateral Thalamic Lesions Associated with Atezolizumab-induced Autoimmune Encephalitis.
    Neurology. 2020 Dec 2. pii: WNL.0000000000011297.
    >> Share

  127. NAISMITH RT, Bermel RA, Coffey CS, Goodman AD, et al
    Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study.
    Neurology. 2020 Dec 2. pii: WNL.0000000000011314.
    >> Share

  128. LANGESKOV-CHRISTENSEN M, Grondahl Hvid L, Nygaard MKE, Ringgaard S, et al
    Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011241.
    >> Share

  129. BINZER S, Manouchehrinia A, Hillert J
    Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1026.
    >> Share

  130. BSTEH G, Berger T
    Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025-1026.
    >> Share

  131. GANESH A, Galetta S
    Editors' note: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025.
    >> Share

  132. SPATOLA M, Petit Pedrol M, Maudes E, Simabukuro M, et al
    Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
    Neurology. 2020;95:e3012-e3025.
    >> Share

    November 2020
  133. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study.
    Neurology. 2020 Nov 25. pii: WNL.0000000000011219.
    >> Share

  134. LI V, Malladi P, Simeoni S, Pakzad M, et al
    A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.
    Neurology. 2020;95:e2924-e2934.
    >> Share

  135. MANTEGAZZA R, Wolfe GI, Muppidi S, Wiendl H, et al
    Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension.
    Neurology. 2020 Nov 23. pii: WNL.0000000000011207.
    >> Share

  136. BRIL V, Benatar M, Andersen H, Vissing J, et al
    Efficacy and safety of rozanolixizumab in moderate-to-severe generalised myasthenia gravis: A phase 2 RCT.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011108.
    >> Share

  137. FEIBEL RM
    Henry R. Viets, MD, and the history of myasthenia gravis.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011239.
    >> Share

  138. NARAYANASWAMI P, Sanders DB, Wolfe G, Benatar M, et al
    International consensus guidance for management of myasthenia gravis: 2020 update.
    Neurology. 2020 Nov 3. pii: WNL.0000000000011124.
    >> Share

  139. HOANG P, Hurtubise B, Muppidi S
    Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
    Neurology. 2020;95:840-843.
    >> Share

    October 2020
  140. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    Reliability of outcome measures in clinical trials in secondary progressive multiple sclerosis.
    Neurology. 2020 Oct 26. pii: WNL.0000000000011123.
    >> Share

  141. KLEIN DA COSTA B, Brant de Souza Melo R, Passos GRD, Gomes Meneses Sevilha Castro D, et al
    Unraveling B lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets.
    Neurology. 2020;95:733-744.
    >> Share

  142. MASTRANGELO V, Asioli GM, Foschi M, Padroni M, et al
    Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease.
    Neurology. 2020;95:648-649.
    >> Share

  143. FELIPE-RUCIAN A, Wegener-Panzer A, Nassenstein I, Reindl M, et al
    Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies.
    Neurology. 2020;95:e2045-e2046.
    >> Share

    September 2020
  144. RINGELSTEIN M, Harmel J, Zimmermann H, Brandt AU, et al
    Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;95:610.
    >> Share

  145. CHEN JJ
    Reader response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;95:609-610.
    >> Share

  146. GIANNOCCARO MP, Paolucci M, Zenesini C, Di Stasi V, et al
    Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis.
    Neurology. 2020;95:e1800-e1806.
    >> Share


  147. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.
    Neurology. 2020 Sep 16. pii: WNL.0000000000008927.
    >> Share

  148. MOCCIA M, van de Pavert S, Eshaghi A, Haider L, et al
    Pathological correlates of the magnetization transfer ratio in multiple sclerosis.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010909.
    >> Share

  149. SHELLY S, Paul P, Bi H, Dubey D, et al
    Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010910.
    >> Share

  150. ROTSTEIN DL, Yeh EA
    Could wider social networks prevent disability in MS and other neurologic disorders?
    Neurology. 2020;95:463-464.
    >> Share

  151. LIBERATORE G, De Santis T, Doneddu PE, Gentile F, et al
    Clinical Reasoning: A case of COVID-19 associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.
    Neurology. 2020 Sep 11. pii: WNL.0000000000010817.
    >> Share

  152. KULICK-SOPER CV, McKee JL, Wolf RL, Mohan S, et al
    Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.
    Neurology. 2020;95:454-457.
    >> Share

  153. VIRHAMMAR J, Kumlien E, Fallmar D, Frithiof R, et al
    Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.
    Neurology. 2020;95:445-449.
    >> Share

  154. BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
    Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:409.
    >> Share

  155. NI J, Xu X
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:408-409.
    >> Share

  156. SIEGLER JE 3RD, Galetta S
    Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:408.
    >> Share

  157. SEESE RR, Guillen D, Gaesser JM, Abdel-Hamid HZ, et al
    Clinical Reasoning: A 14-year-old boy with acute weakness, paresthesias, and headache.
    Neurology. 2020;95:e1285-e1289.
    >> Share

  158. KWON YN, Jung JH, Kim SJ, Sung JJ, et al
    Progressive brain atrophy and white matter changes in MOG encephalomyelitis.
    Neurology. 2020;95:402-403.
    >> Share

    August 2020
  159. BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
    Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:370.
    >> Share

  160. VAVOUGIOS GD
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:369.
    >> Share

  161. VAIRA LA, Salzano G, De Riu G
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:368-369.
    >> Share

  162. LEWIS A, Galetta S
    Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:368.
    >> Share

  163. WALLIN MT
    Initial highly effective therapy for MS: A strong start.
    Neurology. 2020;95:e1114-e1116.
    >> Share

  164. SECHI E, Markovic SN, McKeon A, Dubey D, et al
    Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
    Neurology. 2020 Aug 13. pii: WNL.0000000000010632.
    >> Share

  165. DOUGHTY CT, Guidon AC
    Stronger together: Diagnostic testing for ocular myasthenia gravis.
    Neurology. 2020 Aug 11. pii: WNL.0000000000010616.
    >> Share

  166. RUPRECHT K, Pfuhl C, Oechtering J
    Author response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:277-278.
    >> Share

  167. ALCALA C, Perez-Miralles FC, Gil-Perotin S, Casanova B, et al
    Reader response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:277.
    >> Share

  168. SIEGLER JE 3RD, Galetta S
    Editors' note: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:276.
    >> Share

  169. OUTTERYCK O, Lopes R, Drumez E, Labreuche J, et al
    Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome.
    Neurology. 2020;95:e733-e744.
    >> Share

  170. VAN KEMPEN ZLE, Hoogervorst ELJ, Wattjes MP, Kalkers NF, et al
    Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial.
    Neurology. 2020;95:e745-e754.
    >> Share

  171. DIXON L, Shah S
    Teaching NeuroImages: Hypertrophic polyneuropathy.
    Neurology. 2020;95:e779-e780.
    >> Share

  172. LEE I, Kuo HC, Aban IB, Cutter GR, et al
    Minimal manifestation status and prednisone withdrawal in the MGTX trial.
    Neurology. 2020;95:e755-e766.
    >> Share

  173. ARINO H, Munoz-Lopetegi A, Martinez-Hernandez E, Armangue T, et al
    Sleep disorders in anti-NMDAR encephalitis.
    Neurology. 2020;95:e671-e684.
    >> Share

  174. LEVIN SN, Riley CS, Dhand A, White CC, et al
    Association of Social Network Structure and Physical Function in Patients With Multiple Sclerosis.
    Neurology. 2020 Aug 7. pii: WNL.0000000000010460.
    >> Share

  175. MENDOZA M, Tran C, Bril V, Katzberg HD, et al
    Patient-acceptable symptom states in myasthenia gravis.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010574.
    >> Share

  176. PIEHL F, Wolfe GI
    Is the treatment of myasthenia gravis improving? Why not ask our patients?
    Neurology. 2020 Aug 5. pii: WNL.0000000000010578.
    >> Share

  177. DINKIN M, Gao V, Kahan J, Bobker S, et al
    COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.
    Neurology. 2020;95:221-223.
    >> Share

  178. GUTIERREZ-ORTIZ C, Mendez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, et al
    Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:e601-e605.
    >> Share

  179. NELSON LM, Bourdette D
    Two decades of research: Time to incorporate comorbidity management into the care of MS?
    Neurology. 2020;95:193-194.
    >> Share

  180. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    >> Share

  181. BOSE G, Fitzpatrick T, Yogendrakumar V, Zwicker JC, et al
    Clinical Reasoning: A 73-year-old man with recurrent aphasia, headaches and confusion.
    Neurology. 2020 Aug 4. pii: WNL.0000000000010475.
    >> Share

    July 2020
  182. KILLESTEIN J, Du Pasquier R, Hemmer B
    Vaccination in B-cell depleted MS patients.
    Neurology. 2020 Jul 29. pii: WNL.0000000000010378.
    >> Share

  183. BAR-OR A, Calkwood JC, Chognot C, Evershed J, et al
    Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
    Neurology. 2020 Jul 29. pii: WNL.0000000000010380.
    >> Share

  184. VILLOSLADA P, Sanchez-Dalmau B, Galetta S
    Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosis.
    Neurology. 2020 Jul 28. pii: WNL.0000000000009840.
    >> Share

  185. HAUSER SL, Kappos L, Arnold DL, Bar-Or A, et al
    Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010376.
    >> Share

  186. SANTORO JD, Waltz M, Aaen G, Belman A, et al
    Pediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010414.
    >> Share

  187. KAPOOR R, Smith KE, Allegretta M, Arnold DL, et al
    Serum neurofilament light as a biomarker in progressive multiple sclerosis.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010346.
    >> Share

  188. HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
    Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010369.
    >> Share

  189. HERMAN C, Mayer K, Sarwal A
    Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.
    Neurology. 2020;95:77-84.
    >> Share

  190. CHEN JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, et al
    Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
    Neurology. 2020;95:e111-e120.
    >> Share

  191. MANISCALCO GT, Mariotto S, Hoftberger R, Capra R, et al
    GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010310.
    >> Share

  192. GIOVANNONI G, Knappertz V, Steinerman JR, Tansy AP, et al
    A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010284.
    >> Share

  193. FERREIRA D, Ferro D, Bastos G, Pinto M, et al
    Teaching NeuroImages: Useless (and restless) hand of Oppenheim in multiple sclerosis.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010261.
    >> Share

  194. TOMSCHIK M, Hilger E, Rath J, Mayer EM, et al
    Subgroup Stratification and Outcome in Recently Diagnosed Generalized Myasthenia Gravis.
    Neurology. 2020 Jul 8. pii: WNL.0000000000010209.
    >> Share

  195. BURON MD, Chalmer TA, Sellebjerg F, Barzinji I, et al
    Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
    Neurology. 2020 Jul 7. pii: WNL.0000000000010135.
    >> Share

    June 2020
  196. PONCIANO A, Carvalho JN, Gala D, Leite J, et al
    Pearls & Oy-sters: Guillain-Barre syndrome: An unusual presentation of acute intermittent porphyria.
    Neurology. 2020 Jun 19. pii: WNL.0000000000009838.
    >> Share

  197. RUITER AM, Naber WC, Tannemaat MR, Verschuuren JJGM, et al
    The face of myasthenia gravis.
    Neurology. 2020 Jun 10. pii: WNL.0000000000009782.
    >> Share

  198. JONSSON DI, Sveinsson O, Hakim R, Brundin L, et al
    Author response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
    Neurology. 2020;94:1049-1050.
    >> Share

  199. PAPP V, Petersen T, Magyari M, Koch-Henriksen N, et al
    Reader response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
    Neurology. 2020;94:1048-1049.
    >> Share

  200. VAN KEMPEN ZLE, Kryscio RJ, Dalla Costa G
    Serum neurofilament light as a prognostic marker for MS disability: Are we there yet?
    Neurology. 2020;94:1013-1014.
    >> Share

  201. DAVION JB, Lopes R, Drumez E, Labreuche J, et al
    Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
    Neurology. 2020;94:e2468-e2478.
    >> Share

  202. BIRCA V, Saint-Martin C, Myers KA
    Teaching Video NeuroImages: Pathologic yawning: A sign of brainstem involvement in acute disseminated encephalomyelitis?
    Neurology. 2020;94:e2497-e2498.
    >> Share

  203. COSTELLO F, Dalakas MC
    Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
    Neurology. 2020 Jun 2. pii: WNL.0000000000009921.
    >> Share

  204. ALLENBACH Y, Uzunhan Y, Toquet S, Leroux G, et al
    Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
    Neurology. 2020 Jun 2. pii: WNL.0000000000009727.
    >> Share

  205. GUIDON AC, Amato AA
    COVID-19 and neuromuscular disorders.
    Neurology. 2020;94:959-969.
    >> Share

  206. MARRIE RA, Leavitt VM
    Disease-modifying therapies as cognition-modifying therapies? Treating cognitive impairment in MS.
    Neurology. 2020;94:957-958.
    >> Share

  207. MARTINEZ-HERNANDEZ E, Guasp M, Garcia-Serra A, Maudes E, et al
    Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.
    Neurology. 2020;94:e2302-e2310.
    >> Share

  208. CORREALE J, Marrodan M, Benarroch EE
    What is the role of axonal ion channels in multiple sclerosis?
    Neurology. 2020 Jun 1. pii: WNL.0000000000009754.
    >> Share

    May 2020
  209. LUBLIN FD, Coetzee T, Cohen JA, Marrie RA, et al
    The 2013 clinical course descriptors for multiple sclerosis: A clarification.
    Neurology. 2020 May 29. pii: WNL.0000000000009636.
    >> Share

  210. RAFAY MF, Shapiro KA, Surmava AM, deVeber GA, et al
    Spectrum of cerebral arteriopathies in children with arterial ischemic stroke.
    Neurology. 2020 May 26. pii: WNL.0000000000009557.
    >> Share

  211. MANOUCHEHRINIA A, Stridh P, Khademi M, Leppert D, et al
    Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis.
    Neurology. 2020 May 20. pii: WNL.0000000000009571.
    >> Share

  212. LANDMEYER NC, Burkner PC, Wiendl H, Ruck T, et al
    Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
    Neurology. 2020 May 19. pii: WNL.0000000000009522.
    >> Share

  213. LAMBE J, Rothman A, Prince J, Saidha S, et al
    Retinal pathology occurs in stiff-person syndrome.
    Neurology. 2020;94:e2126-e2131.
    >> Share

  214. DALE RC, Rostasy K
    Autoimmune pediatric neuropsychiatric symptoms with pain and hypertension: CASPR2 antibody.
    Neurology. 2020 May 18. pii: WNL.0000000000009521.
    >> Share

  215. SYRBE S, Stettner GM, Bally J, Borggraefe I, et al
    CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
    Neurology. 2020 May 18. pii: WNL.0000000000009523.
    >> Share

  216. MATHIS S, Soulages A, Le Masson G, Vallat JM, et al
    History of acute polyradiculoneuropathy (part 2): From 1916 to 2019.
    Neurology. 2020;94:836-840.
    >> Share

  217. VAN OMMEREN R, Izenberg A, Shadowitz S, Aviv R, et al
    Clinical Reasoning: An 81-year-old woman with decreased consciousness and fluctuating right facial droop.
    Neurology. 2020;94:843-848.
    >> Share

  218. CORTESE M, Munger KL, Martinez-Lapiscina EH, Barro C, et al
    Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
    Neurology. 2020;94:e1950-e1960.
    >> Share

  219. GADOT R, Nascimento FA, Mims M, Nunez-Wallace K, et al
    Clinical Reasoning: A 59-year-old woman with multiple myeloma and lower extremity weakness and numbness.
    Neurology. 2020;94:794-800.
    >> Share

    April 2020
  220. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    >> Share

  221. MATHIS S, Soulages A, Vallat JM, Le Masson G, et al
    History of acute polyradiculoneuropathy (part 1): The prehistory of Guillain-Barre syndrome.
    Neurology. 2020 Apr 28. pii: WNL.0000000000009401.
    >> Share

  222. KIM HW, Lamb C, Jamali S, Lopez Chiriboga AS, et al
    Mystery Case: Anti-NMDAR encephalitis with overlapping demyelinating syndrome.
    Neurology. 2020;94:e1866-e1869.
    >> Share

  223. NISHI R, Koike H, Ohyama K, Fukami Y, et al
    Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.
    Neurology. 2020;94:e1726-e1737.
    >> Share

  224. POUPART J, Giovannelli J, Deschamps R, Audoin B, et al
    Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
    Neurology. 2020;94:e1645-e1656.
    >> Share

  225. HUSSEIN O, Jordan Z, Abd Elazim A, Stino A, et al
    Pearls & Oy-sters: Rapid progression of prion disease associated with transverse myelitis: A rare presentation.
    Neurology. 2020;94:e1670-e1672.
    >> Share

  226. LANGER-GOULD A, Smith JB, Albers KB, Xiang AH, et al
    Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.
    Neurology. 2020 Apr 13. pii: WNL.0000000000009374.
    >> Share

  227. DOBSON R, Mowry EM
    Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.
    Neurology. 2020 Apr 13. pii: WNL.0000000000009369.
    >> Share

  228. MEALY MA, Kozachik SL, Cook LJ, Totonis L, et al
    Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.
    Neurology. 2020 Apr 8. pii: WNL.0000000000009370.
    >> Share

  229. LEAVITT VM
    Neurologic determinism? Key update to an age-old debate.
    Neurology. 2020;94:605-606.
    >> Share

  230. BROWNLEE W, Bourdette D, Broadley S, Killestein J, et al
    Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
    Neurology. 2020 Apr 2. pii: WNL.0000000000009507.
    >> Share

    March 2020
  231. CARVALHO NETO EG, Gomes MF, Dos Santos IP, Monteiro MD, et al
    Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis: The phenomenon of enhanced ptosis.
    Neurology. 2020 Mar 31. pii: WNL.0000000000009238.
    >> Share

  232. DE MEEL RHP, Keene KR, Wirth MA, Weber KP, et al
    Repetitive ocular vestibular evoked myogenic potentials in myasthenia gravis.
    Neurology. 2020 Mar 26. pii: WNL.0000000000009306.
    >> Share

  233. GRONSETH GS, Barohn R, Narayanaswami P
    Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2020 Mar 25. pii: WNL.0000000000009294.
    >> Share

  234. ARGYROPOULOS GPD, Moore L, Loane C, Roca-Fernandez A, et al
    Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis.
    Neurology. 2020;94:e1320-e1335.
    >> Share

  235. YEH EA, Sormani MP
    Tracking therapies in MS: More evidence in favor of neurofilament.
    Neurology. 2020;94:465-466.
    >> Share

  236. RICE J, Woltjer R, Stienstra N, Sun E, et al
    Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage.
    Neurology. 2020;94:e992-e995.
    >> Share

    February 2020
  237. MACARON G, Willis MA, Ontaneda D, Fernandez H, et al
    Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.
    Neurology. 2020;94:273-275.
    >> Share

  238. KAPOOR M, Spillane J, Englezou C, Sarri-Gonzalez S, et al
    Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.
    Neurology. 2020;94:e635-e638.
    >> Share

  239. LIPKA AF, Boldingh MI, van Zwet EW, Schreurs MWJ, et al
    Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.
    Neurology. 2020;94:e511-e520.
    >> Share

    January 2020
  240. HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
    Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies.
    Neurology. 2020 Jan 20. pii: WNL.0000000000008978.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016